-
Mashup Score: 1Highlights from iwCLL 2021 - 3 year(s) ago
The management of chronic lymphocytic leukemia (CLL) has evolved drastically over the last few years, with the introduction of novel…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Sequencing of targeted therapies for CLL - 3 year(s) ago
Adrian Wiestner, MD, PhD, National Institutes of Health, Bethesda, MD, talks on the different strategies to sequence targeted therapies for…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
During the XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL), the Lymphoma Hub spoke with Richard Rosenquist, Karolinska Institutet, Stockholm, SE. We asked, How can we select the best targeted agent(s) for patients with chronic lymphocytic leukemia (CLL)?
Source: lymphomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Acalabrutinib, Alone or With Obinutuzumab, Improves Quality-Adjusted Survival in Frontline CLL - 3 year(s) ago
Treatment with acalabrutinib as monotherapy or in combination with obinutuzumab improved quality-adjusted survival compared with chlorambucil plus obinutuzumab in patients with treatment-naΓ―ve chronic lymphocytic leukemia.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Dr. John Byrd Presented the Binet-Rai Medal Award at XIX International Workshop on Chronic Lymphocytic Leukemia - 3 year(s) ago
During the XIX International Workshop on Chronic Lymphocytic Leukemia, which occurred virtually 17-20 September, Dr. John Byrd was presented the Binet-Rai Medal Award for his outstanding findings, which led to the use of BTK Inhibitors in almost every phase of CLL therapy.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 10The effect of COVID-19 on CLL patient experiences - 3 year(s) ago
Zack Pemberton-Whiteley, Leukemia Care, Worcester, UK, discusses the findings of a study investigating the experiences of patients with chronic lymphocytic…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1TG-1701 Monotherapy or Plus Ublituximab/Umbralisib Shows Encouraging Results in Relapsed/Refractory CLL - 3 year(s) ago
TG-1701, a covalently bound BTK inhibitor, used as monotherapy or in combination with umbralisib and ublituximab, demonstrated promising activity and a manageable safety profile in patients with chronic lymphocytic leukemia.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2VJHemOnc β The video journal of hematological oncology - 3 year(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Addressing autoimmune cytopenia in CLL - 3 year(s) ago
Kerry Rogers, MD, The Ohio State University, Columbus, OH, discusses the management of autoimmune cytopenia in patients with chronic lymphocytic…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1VJHemOnc β The video journal of hematological oncology - 3 year(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
It's the final day of #iwCLL2021 but we're still adding more updates from the experts π©ββοΈπ¨ββοΈ Canβt make it? weβll be covering all the latest here πhttps://t.co/O9p0vDBrzw π Be sure to follow us for #HemOnc news β‘οΈ @VJHemOnc @iwCLL #CLLsm #LEUsm #Leukemia #HemOnc https://t.co/byujYBVdW0
-
Don't miss our #VJSounds podcast bringing you highlights from #iwCLL2021! Including updates from Paolo Ghia, Lydia Scarfo (@ScarfoLydia), Richard Rosenquist (@rosenquistbrand)! π¨ββοΈπ©ββοΈ π§ Listen: https://t.co/KifiuxOqXm @VJHemOnc @iwCLL #CLLsm #LEUsm #LYMsm #Lymphoma #Leukemia